Shuttle Pharmaceuticals Holdings, Inc. (SHPH) SEC Filings — 2024

Filings

• Shuttle Pharmaceuticals Files 8-K with Material Agreement — 8-K · Dec 19, 2024
• Shuttle Pharmaceuticals Files 8-K — 8-K · Nov 26, 2024
• Shuttle Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 13, 2024
• Shuttle Pharmaceuticals Announces Material Agreement — 8-K · Nov 1, 2024
• Shuttle Pharmaceuticals Files 8-K — 8-K · Oct 29, 2024
• Shuttle Pharmaceuticals Holdings, Inc. 8-K Filing — 8-K · Oct 28, 2024
• Shuttle Pharmaceuticals Enters Material Agreement, Reports Equity Sales — 8-K · Oct 25, 2024
• Shuttle Pharmaceuticals Files S-1/A Update — S-1/A · Oct 18, 2024
• Shuttle Pharmaceuticals Enters Material Agreement — 8-K · Oct 17, 2024
• Shuttle Pharmaceuticals Files S-1 — S-1 · Sep 20, 2024
• Shuttle Pharmaceuticals Faces Nasdaq Listing Rule Violation — 8-K · Sep 13, 2024
• Shuttle Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 10, 2024
• Shuttle Pharmaceuticals Files 10-K Amendment — 10-K/A · Sep 4, 2024
• Shuttle Pharmaceuticals to Acquire 03 Life Sciences — 8-K · Aug 28, 2024
• Shuttle Pharmaceuticals Faces Delisting Notice — 8-K · Aug 26, 2024
• Shuttle Pharmaceuticals (SHPH) Lists on Nasdaq — 8-K · Aug 14, 2024
• Shuttle Pharmaceuticals Enters Material Agreement, Modifies Security Holder Rights — 8-K · Aug 7, 2024
• Shuttle Pharmaceuticals Files 8-K on Shareholder Matters — 8-K · Aug 1, 2024
• Shuttle Pharmaceuticals Restates Financials — 8-K · Jul 16, 2024
• Shuttle Pharmaceuticals Files 2024 Proxy Statement — DEF 14A · Jun 20, 2024
• Shuttle Pharmaceuticals Elects New Directors, Reports Other Events — 8-K · Jun 18, 2024
• Shuttle Pharmaceuticals Files 8-K — 8-K · May 22, 2024
• Shuttle Pharmaceuticals Files 8-K on Financials — 8-K · May 14, 2024
• Shuttle Pharmaceuticals Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 13, 2024
• Shuttle Pharma Collaborates with NCI on Cancer Therapies — 8-K · Apr 29, 2024
• Shuttle Pharmaceuticals Files 8-K — 8-K · Apr 23, 2024
• Shuttle Pharmaceuticals Holdings, Inc. Files S-1 Registration Statement — S-1 · Apr 5, 2024
• Shuttle Pharmaceuticals Files 8-K on Financials — 8-K · Mar 22, 2024
• Shuttle Pharmaceuticals Holdings, Inc. Files 2023 Annual Report — 10-K · Mar 21, 2024
• Shuttle Pharmaceuticals Faces Delisting Concerns — 8-K · Mar 5, 2024
• Shuttle Pharma Reports Material Agreement & Equity Sale — 8-K · Feb 13, 2024
• SHPH Files 8-K on Material Agreement; Details Undisclosed — 8-K · Feb 5, 2024
• Shuttle Pharma Files 8-K: Routine Admin Update, Nasdaq Listing Confirmed — 8-K · Jan 8, 2024